BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 35191607)

  • 1. Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3 inflammasome inhibition.
    Shi M; Wang J; Bi F; Bai Z
    Environ Toxicol; 2022 Jun; 37(6):1529-1542. PubMed ID: 35191607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SET domain containing 7 promotes oxygen-glucose deprivation/reoxygenation-induced PC12 cell inflammation and oxidative stress by regulating Keap1/Nrf2/ARE and NF-κB pathways.
    Pan X; Fan J; Peng F; Xiao L; Yang Z
    Bioengineered; 2022 Mar; 13(3):7253-7261. PubMed ID: 35259059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosmetin alleviated cerebral ischemia/reperfusion injury
    Mei Z; Du L; Liu X; Chen X; Tian H; Deng Y; Zhang W
    Food Funct; 2022 Jan; 13(1):198-212. PubMed ID: 34881386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 inflammasome deficiency attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis.
    Wang Z; Li Y; Ye Y; Zhu H; Zhang J; Wang H; Lei J; Gu L; Zhan L
    Brain Res Bull; 2023 Feb; 193():37-46. PubMed ID: 36435361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D alleviates neuronal injury in cerebral ischemia-reperfusion via enhancing the Nrf2/HO-1 antioxidant pathway to counteract NLRP3-mediated pyroptosis.
    Qiao J; Ma H; Chen M; Bai J
    J Neuropathol Exp Neurol; 2023 Jul; 82(8):722-733. PubMed ID: 37403613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1/Nrf2 signaling.
    Ren X; Yu J; Guo L; Ma H
    Int Immunopharmacol; 2021 Jul; 96():107595. PubMed ID: 33812256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
    Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
    Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence marker protein 30 confers neuroprotection in oxygen-glucose deprivation/reoxygenation-injured neurons through modulation of Keap1/Nrf2 signaling: Role of SMP30 in OGD/R-induced neuronal injury.
    Liu W; Zhao H; Su Y; Wang K; Li J; Xue S; Sun X; Qiu Z
    Hum Exp Toxicol; 2021 Mar; 40(3):472-482. PubMed ID: 32909858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury.
    Cheng Y; Cheng L; Gao X; Chen S; Wu P; Wang C; Liu Z
    Theranostics; 2021; 11(2):861-877. PubMed ID: 33391509
    [No Abstract]   [Full Text] [Related]  

  • 10. Pratensein Mitigates Oxidative Stress and NLRP3 Inflammasome Activation in OGD/R-Injured HT22 Cells by Activating Nrf2-Anti-oxidant Signaling.
    Wang R; Wei Y; Deng W; Teng J
    Neurotox Res; 2022 Apr; 40(2):384-394. PubMed ID: 35064904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rd attenuates cerebral ischemia/reperfusion injury by exerting an anti-pyroptotic effect via the miR-139-5p/FoxO1/Keap1/Nrf2 axis.
    Yao Y; Hu S; Zhang C; Zhou Q; Wang H; Yang Y; Liu C; Ding H
    Int Immunopharmacol; 2022 Apr; 105():108582. PubMed ID: 35124564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethylnobiletin ameliorates cerebral ischemia-reperfusion injury in rats through Nrf2/HO-1 signaling pathway.
    Huang D; Awad ACA; Tang C; Chen Y
    Environ Toxicol; 2024 Mar; 39(3):1335-1349. PubMed ID: 37955318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bakuchiol ameliorates cerebral ischemia-reperfusion injury by modulating NLRP3 inflammasome and Nrf2 signaling.
    Xu Y; Gao X; Wang L; Yang M; Xie R
    Respir Physiol Neurobiol; 2021 Oct; 292():103707. PubMed ID: 34087492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of
    Zhang Z; Pang X; Wei Y; Chen H; Jin X; Lv Q
    Brain Inj; 2023 Mar; 37(4):269-281. PubMed ID: 36567616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2.
    Xiao L; Dai Z; Tang W; Liu C; Tang B
    Oxid Med Cell Longev; 2021; 2021():9925561. PubMed ID: 35003524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling.
    Zhao J; Piao X; Wu Y; Liang S; Han F; Liang Q; Shao S; Zhao D
    Biomed Pharmacother; 2020 Jul; 127():110151. PubMed ID: 32559840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen sulfide attenuates renal I/R‑induced activation of the inflammatory response and apoptosis via regulating Nrf2‑mediated NLRP3 signaling pathway inhibition.
    Su Y; Wang Y; Liu M; Chen H
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKIP-1 alleviates oxygen-glucose deprivation/reoxygenation-induced apoptosis and oxidative stress in cultured hippocampal neurons by downregulating Keap1 and activating Nrf2/ARE signaling.
    Xiang Y; Fan X; Zhao M; Guo Q; Guo S
    Eur J Pharmacol; 2019 Apr; 848():140-149. PubMed ID: 30658115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-34b Protects Against Focal Cerebral Ischemia-Reperfusion (I/R) Injury in Rat by Targeting Keap1.
    Huang R; Ma J; Niu B; Li J; Chang J; Zhang Y; Liu P; Luan X
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):1-9. PubMed ID: 30539753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procyanidins exhibits neuroprotective activities against cerebral ischemia reperfusion injury by inhibiting TLR4-NLRP3 inflammasome signal pathway.
    Yang B; Sun Y; Lv C; Zhang W; Chen Y
    Psychopharmacology (Berl); 2020 Nov; 237(11):3283-3293. PubMed ID: 32729095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.